Akeega
Akeega ingredients
| Active ingredient | Strength |
|---|---|
| Niraparib Tosylate Monohydrate | 100 mg/1, 50 mg/1 |
| Abiraterone Acetate | 500 mg/1 |
What Akeega is used for
The FDA lists the approved uses on the official label (below). In the EU, niraparib;abiraterone acetate is approved as Akeega for:
Treatment of adult patients with prostate cancer.
EU wording from the European Medicines Agency; US approved uses can differ.
Key facts
- Brand
- Akeega
- Generic name
- Niraparib tosylate monohydrate and abiraterone acetate
- Made by
- Janssen Biotech, Inc.
- Forms
- Tablet, Film Coated
- Given
- Oral
- Drug class
- Cytochrome P450 17A1 Inhibitor, Poly(ADP-Ribose) Polymerase Inhibitor
- FDA approval
- New drug application (NDA) NDA216793
- On the US market since
- 2023
Official information
- Akeega prescribing information (FDA label) on DailyMed
- MedlinePlus drug information (search for Niraparib tosylate monohydrate and abiraterone acetate)
In India
- Abiraterone acetate: 45 brands in India
Specialist medicine: started and supervised by a specialist doctor or hospital. This page is a plain-language summary of public official information, not medical advice; follow your doctor and the official product information.
Common questions
What is Akeega?
Akeega (Niraparib tosylate monohydrate and abiraterone acetate) is a cancer medicine made by Janssen Biotech, Inc., approved by the US FDA.
What are the ingredients of Akeega?
Akeega contains Niraparib Tosylate Monohydrate (100 mg/1, 50 mg/1); Abiraterone Acetate (500 mg/1).
Is Akeega approved in Europe?
The same active substance is approved in the EU as Akeega, Zytiga.
From the FDA National Drug Code directory (open.fda.gov, public domain) and the European Medicines Agency medicines list. Page made 5 November 2026 by Satya Babu.
← All specialty medicines, USA